MTM Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.6K Hold
124
0.01% 347
2025
Q4
$40.6K Hold
124
0.01% 357
2025
Q3
$35K Sell
124
-77
-38% -$22.3K 0.01% 388
2025
Q2
$56.1K Buy
+201
New +$56.9K 0.02% 322
2021
Q4
Sell
-987
Closed -$210K 288
2021
Q3
$210K Sell
987
-60
-6% -$13.8K 0.11% 158
2021
Q2
$255K Sell
1,047
-812
-44% -$200K 0.13% 135
2021
Q1
$463K Buy
1,859
+418
+29% +$99.7K 0.26% 97
2020
Q4
$331K Buy
+1,441
New +$332K 0.2% 108

Other funds holding AMGN

MTM Investment Management's AMGN Position: Q1 2026 in Review

MTM Investment Management held its Amgen (AMGN) position steady in Q1 2026 at 124 shares worth $43.6K. The position accounts for 0.01% of the portfolio, ranked #347.

MTM Investment Management first reported a position in AMGN in Q4 2020 and has held it in 8 quarters since. The position peaked at $463K in Q1 2021. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • MTM Investment Management held 124 shares of Amgen worth $43.6K as of Q1 2026.
  • MTM Investment Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.01% of MTM Investment Management's portfolio in Q1 2026, its #347 holding.
  • MTM Investment Management first reported a position in Amgen in Q4 2020 and has held it in 8 quarters since.
  • MTM Investment Management's Amgen position peaked at $463K in Q1 2021.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on MTM Investment Management's 13F filing for Q1 2026, filed 6 May 2026.